The current state of hormonal therapy for prostate cancer

Beth A. Hellerstedt, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.

Original languageEnglish (US)
Pages (from-to)154-179
Number of pages26
JournalCa-A Cancer Journal for Clinicians
Volume52
Issue number3
StatePublished - 2002
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this